Mobilizing Action on AMR – Why collaboration with the NCD Community is Key to Better Treatment Outcomes
This session is a collaboration between the Norwegian Cancer Society, the Union for International Cancer Control (UICC), the Swedish Cancer Society, GARDP and the Permanent Mission of Norway to the United Nations.
Antimicrobial resistance (AMR) is a growing global threat that undermines the effectiveness of essential treatments like antibiotics and antifungals, especially impacting cancer patients who are more vulnerable to infections. This side event aims to mobilise the NCD and AMR communities to highlight the urgent need to address AMR for better NCD care outcomes and underscore the importance of civil society in driving a comprehensive and effective AMR response.
Privacy policy
By ticking the box below, I authorise UICC to use the personal data provided to support the logistical organisation of my participation in the event, I also agree to the UICC Privacy policy.